Trademark: 97002544
Word
XPAC
Status
Registered
Status Code
700
Status Date
Tuesday, April 4, 2023
Serial Number
97002544
Registration Number
7015434
Registration Date
Tuesday, April 4, 2023
Mark Type
4000
Filing Date
Monday, August 30, 2021
Published for Opposition
Tuesday, January 17, 2023

Trademark Owner History
Amunix Pharmaceuticals, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of cancerous, inflammatory, immunological, and viral diseases; pharmaceutical preparations for use in the field of oncology, immunology, and inflammation for the treatment of cancer, asthma, atopic dermatitis, peripheral inflammatory diseases, cardiovascular disease, autoimmune diseases; medical diagnostic reagents; reagents for use in testing proteins for medical and diagnostic purposes
1 Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations

Trademark Events
Apr 4, 2023
Notice Of Registration Confirmation Emailed
Apr 4, 2023
Registered-Principal Register
Jan 17, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 17, 2023
Published For Opposition
Dec 28, 2022
Notification Of Notice Of Publication E-Mailed
Dec 9, 2022
Approved For Pub - Principal Register
Dec 3, 2022
Teas/Email Correspondence Entered
Dec 2, 2022
Correspondence Received In Law Office
Dec 2, 2022
Teas Response To Office Action Received
Jun 2, 2022
Notification Of Non-Final Action E-Mailed
Jun 2, 2022
Non-Final Action E-Mailed
Jun 2, 2022
Non-Final Action Written
Jun 2, 2022
Assigned To Examiner
Oct 13, 2021
New Application Office Supplied Data Entered
Sep 2, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24